Are there cost-saving programs for Tecentriq?
Tecentriq is an expensive cancer medication, but there may be options to help you afford this medicine, no matter the type of insurance you have or if you have no insurance at all.
For the most current Tecentriq prices, see:
You can use online tools from Genentech, the manufacturer, to help explore financial options and determine which programs you may qualify for. You can also call Genentech at 1-888-249-4918 (6AM-5PM PST, Monday through Friday) for direct assistance.
Tecentriq (atezolizumab) is a programmed death-ligand 1 (PD-L1) blocking antibody (or immune checkpoint inhibitor) used in the treatment of:
- non-small cell lung cancer (NSCLC)
- small cell lung cancer (SCLC)
- heptatocellular (liver) cancer (HCC)
- melanoma (a serious skin cancer)
- alveolar soft part sarcoma (ASPS), a rare soft tissue tumor
Tecentriq is supplied as an injection in a single-dose vial in the following strengths:
- Injection: 840 mg/14 mL (60 mg/mL)
- Injection: 1200 mg/20 mL (60 mg/mL)
This is not all the information you need to know about atezolizumab (Tecentriq) for safe and effective use and does not replace your healthcare provider's instructions. Review the full Tecentriq information and discuss this information and any questions with your doctor or other health care provider.
References
- Tecentriq (atezolizumab) [product information]. Genentech Inc. South San Francisco, CA. Accessed March 20, 2024 at https://www.gene.com/download/pdf/tecentriq_prescribing.pdf
Read next
How effective is atezolizumab (Tecentriq)?
Atezolizumab (Tecentriq) is approved to treat several different types of cancer. Cancer treatment is always individualized for each patient. It’s effectiveness and your length of response will depend upon your diagnosis, previous treatments, and other medical conditions, among other factors. Continue reading
Is atezolizumab (Tecentriq) a chemotherapy or immunotherapy drug?
Atezolizumab (brand name: Tecentriq) is a type of immunotherapy drug called an “immune checkpoint inhibitor”. It helps to stimulate the body’s immune system to fight certain types cancer, including lung, liver and skin cancer. Continue reading
Does atezolizumab (Tecentriq) cause hair loss?
Hair loss (alopecia) is listed as a common side effect with atezolizumab (Tecentriq) when used with certain other cancer treatments. Hair loss was not reported as a side effect when used as a single agent for urothelial (bladder) cancer treatment (but Tecentriq is no longer FDA-approved to be used in bladder cancer). Continue reading
Related medical questions
- How is atezolizumab (Tecentriq) administered?
- What type of cancer is Tecentriq used to treat?
- What is the success rate of Keytruda?
- How long does it take for Keytruda to work?
- What is the difference between Opdivo and Keytruda?
- Pembrolizumab vs. nivolumab: How do they compare?
- What happens when you stop taking Opdivo for melanoma?
- How effective are Opdivo and Yervoy when taken together?
- What is Braftovi used to treat?
- What is Mektovi used to treat?
- Sunscreen Safety: What do you need to know?
- Is small cell or non-small cell lung cancer worse?
- Is non-small cell lung cancer hereditary?
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of lung cancer is Vizimpro used to treat?
- Why give Taxol (Paxel) before carboplatin?
- What is Paxel called in the USA?
- How effective is Lumakras, what's the survival rate?
- How effective is Tabrecta?
- What is the difference between Mvasi and Avastin?
- How does erlotinib work (mechanism of action)?
- How long can I take Gilotrif (afatinib) for?
- Will Tabrecta cure lung cancer?
- How does Retevmo work?
- Is Tabrecta a chemotherapy drug?
- Is Gilotrif (afatinib) a chemotherapy drug?
- How long do you take Alecensa for?
- What is the mechanism of action for Alecensa (alectinib)?
- How effective is Alecensa for ALK-positive NSCLC?
Drug information
Related support groups
- Tecentriq (6 questions, 5 members)
- Atezolizumab (6 questions, 4 members)
- Melanoma (20 questions, 52 members)
- Non-Small Cell Lung Cancer (52 questions, 70 members)
- Hepatocellular Carcinoma (21 questions, 23 members)
- Small Cell Lung Cancer (10 questions, 20 members)
- Alveolar Soft Part Sarcoma (5 questions, 3 members)